Shukra Pharmaceuticals (BOM:524632) EV-to-Revenue : 4.37 (As of May. 25, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Shukra Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shukra Pharmaceuticals's enterprise value is ₹4,802 Mil. Shukra Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,099 Mil. Therefore, Shukra Pharmaceuticals's EV-to-Revenue for today is 4.37.

The historical rank and industry rank for Shukra Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

BOM:524632' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.25 Med: 1.59 Max: 6.51
Current: 4.38

During the past 13 years, the highest EV-to-Revenue of Shukra Pharmaceuticals was 6.51. The lowest was 0.25. And the median was 1.59.

BOM:524632's EV-to-Revenue is ranked worse than
73.14% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs BOM:524632: 4.38

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Shukra Pharmaceuticals's stock price is ₹111.29. Shukra Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹52.35. Therefore, Shukra Pharmaceuticals's PS Ratio for today is 2.13.

Shukra Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Shukra Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shukra Pharmaceuticals EV-to-Revenue Chart

Shukra Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

2.04

1.29

1.45

0.61

0.33

Shukra Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.96	0.33	1.01	1.75	1.23

Competitive Comparison of Shukra Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shukra Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shukra Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shukra Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shukra Pharmaceuticals's EV-to-Revenue falls into.

Shukra Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shukra Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4802.367	/	1099.348
	=	4.37

Shukra Pharmaceuticals's current Enterprise Value is ₹4,802 Mil.
Shukra Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,099 Mil.

Shukra Pharmaceuticals (BOM:524632) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shukra Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	111.29	/	52.349
	=	2.13

Shukra Pharmaceuticals's share price for today is ₹111.29.
Shukra Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹52.35.

Shukra Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shukra Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shukra Pharmaceuticals (BOM:524632) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shukra Pharmaceuticals Ltd (BOM:524632) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054

Website

https://www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.

Shukra Pharmaceuticals (BOM:524632) Headlines

No Headlines